Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin sensitivity pathways represent a complex network of intracellular signaling events that mediate the metabolic and mitogenic effects of insulin. These pathways are crucial for regulating glucose homeostasis and energy metabolism in key tissues like skeletal muscle, liver, and adipose tissue. Impairment of these pathways leads to insulin resistance, a hallmark of type 2 diabetes and metabolic syndrome.
Varies depending on the specific drug and its target within the pathway. Insulin directly activates the pathway via the insulin receptor. Metformin indirectly improves insulin sensitivity. Thiazolidinediones activate PPARG to increase insulin sensitivity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Sensitivity Pathways (N/A).